Recon: CMS to restrict coverage of Aduhelm to only clinical trials; FDA warns of dental issues with buprenorphine
Recon
BiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyReconBiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy